Task: Answer the multiple-choice question.
Question: Which drug exhibits a -14.797% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a NS(=O)(=O)c1cc(C(=O)OCC(=O)N2CCc3ccccc3C2)ccc1Cl
b CCN1C(=O)C(O)(CC(=O)/C=C/C=C/c2ccccc2)c2ccccc21
Answer: a. NS(=O)(=O)c1cc(C(=O)OCC(=O)N2CCc3ccccc3C2)ccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NS(=O)(=O)c1cc(C(=O)OCC(=O)N2CCc3ccccc3C2)ccc1Cl
NS(=O)(=O)c1cc(C(=O)OCC(=O)N2CCc3ccccc3C2)ccc1Cl
2-chloro-5-[[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethoxy]-oxomethyl]benzenesulfonamide